You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 14, 2025

Pharmacia And Upjohn Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PHARMACIA AND UPJOHN, and what generic and branded alternatives to PHARMACIA AND UPJOHN drugs are available?

PHARMACIA AND UPJOHN has seventy-two approved drugs.

Summary for Pharmacia And Upjohn

US Patents:	0
Tradenames:	58
Ingredients:	56
NDAs:	72
Drug Master File Entries:	41

Drugs and US Patents for Pharmacia And Upjohn

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmacia And Upjohn	NEO-CORTEF	hydrocortisone acetate; neomycin sulfate	OINTMENT;TOPICAL	060751-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Pharmacia And Upjohn	HALOTESTIN	fluoxymesterone	TABLET;ORAL	010611-010	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Pharmacia And Upjohn	SOLU-CORTEF	hydrocortisone sodium succinate	INJECTABLE;INJECTION	009866-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Pharmacia And Upjohn	VANCOR	vancomycin hydrochloride	INJECTABLE;INJECTION	062956-002	Aug 1, 1988		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Pharmacia And Upjohn	MEDROL ACETATE	methylprednisolone acetate	OINTMENT;TOPICAL	012421-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Pharmacia And Upjohn	VANTIN	cefpodoxime proxetil	FOR SUSPENSION;ORAL	050675-001	Aug 7, 1992		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Pharmacia And Upjohn

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pharmacia And Upjohn	TYMTRAN	ceruletide diethylamine	INJECTABLE;INJECTION	018296-001	Approved Prior to Jan 1, 1982	3,472,832	⤷ Subscribe
Pharmacia And Upjohn	HYLOREL	guanadrel sulfate	TABLET;ORAL	018104-001	Dec 29, 1982	3,547,951	⤷ Subscribe
Pharmacia And Upjohn	DIZAC	diazepam	INJECTABLE;INJECTION	019287-001	Jun 18, 1993	RE32393	⤷ Subscribe
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-003	Oct 31, 1988	3,755,427	⤷ Subscribe
Pharmacia And Upjohn	HYLOREL	guanadrel sulfate	TABLET;ORAL	018104-002	Dec 29, 1982	3,547,951	⤷ Subscribe
Pharmacia And Upjohn	PROSTIN F2 ALPHA	dinoprost tromethamine	INJECTABLE;INJECTION	017434-001	Approved Prior to Jan 1, 1982	3,657,327	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.